Renalytix AI PLC Director/PDMR Shareholding - Replacement (7366C)
June 22 2021 - 7:25AM
UK Regulatory
TIDMRENX
RNS Number : 7366C
Renalytix AI PLC
22 June 2021
The following amendment(s) has been made to the ' Director/PDMR
Dealing' announcement released on 22 June 2021 at 10:57 under RNS
No 7062C.
The price of 113.5 pence per share was incorrect and has been
amended to 1135 pence per share.
The Company was also informed of the sale 'yesterday'.
All other details remain unchanged.
The full amended text is shown below.
Renalytix AI plc
("Renalytix" or the "Company")
Director/PDMR Dealing
The Company was informed that yesterday, Christopher Mills, a
non-executive director and interim Chairman, completed the sale of
17,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in
the Company at a price of 1135 pence per share.
Following completion of the sale, Christopher Mills is
interested in 9,180,501 Ordinary Shares representing 12.74% of the
current issued share capital of the Company.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Harwood Capital LLP and Harwood Capital
Management (Gibraltar) Limited as
investment manager to North Atlantic
Smaller Companies Investment Trust
plc and Oryx
------------------------------------ -------------------------------------------------
2 Reason for the notification
---------------------------------------------------------------------------------------
a) Position/status Christopher Mills, non-exec director
and Interim Chair of the issuer and
director of NASCIT and Oryx International
Growth Fund Ltd
------------------------------------ -------------------------------------------------
b) Initial notification Initial Notification
/Amendment
------------------------------------ -------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------------------
a) Name Renalytix AI plc
------------------------------------ -------------------------------------------------
b) LEI 213800NTOH3FK3WER551
------------------------------------ -------------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
---------------------------------------------------------------------------------------
a) Description of the Ordinary shares of GBP0.0025 each
financial instrument,
type of instrument
Identification code GB00BYWL4Y04
b) Nature of the transaction Sale of shares
------------------------------------ -------------------------------------------------
c) Currency GBP
------------------------------------ -------------------------------------------------
d) Price(s) and volume(s)
-------------------------- ------------------
Price(s) Volume(s)
-------------------------- ------------------
GBP11.352941 17,000
-------------------------------------------------------------------- ------------------
e) Aggregated information
- Aggregated volume 17,000
- Price GBP192,999.99
f) Date of the transaction 18 June 2021
------------------------------------ -------------------------------------------------
g) Place of the transaction London Stock Exchange
------------------------------------ -------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHZZGZVZZFGMZM
(END) Dow Jones Newswires
June 22, 2021 08:25 ET (12:25 GMT)
Renalytix (LSE:RENX)
Historical Stock Chart
From Apr 2024 to May 2024
Renalytix (LSE:RENX)
Historical Stock Chart
From May 2023 to May 2024
